Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-113881
Filing Date
2025-11-24
Accepted
2025-11-24 09:02:12
Documents
40
Period of Report
2025-11-24

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0266870-6k_enlivex.htm 6-K 46685
2 FORM OF PRE-FUNDED WARRANTS ea026687001ex4-1_enlivex.htm EX-4.1 84187
3 FORM OF LEAD INVESTOR WARRANTS ea026687001ex4-2_enlivex.htm EX-4.2 77483
4 OPINION OF FISCHER (FBC & CO.), ISRAELI COUNSEL TO THE COMPANY ea026687001ex5-1_enlivex.htm EX-5.1 11530
5 SECURITIES PURCHASE AGREEMENT ea026687001ex10-1_enlivex.htm EX-10.1 347470
6 FORM OF REGISTRATION RIGHTS AGREEMENT ea026687001ex10-2_enlivex.htm EX-10.2 194232
7 TREASURY MANAGEMENT AGREEMENT ea026687001ex10-3_enlivex.htm EX-10.3 128722
8 FORM OF SHAREHOLDERS' AGREEMENT ea026687001ex10-4_enlivex.htm EX-10.4 64447
9 ATM SALES AGREEMENT ea026687001ex10-5_enlivex.htm EX-10.5 244566
10 SUPPLEMENTAL RISK FACTORS ea026687001ex99-1_enlivex.htm EX-99.1 94526
11 PRESS RELEASE ea026687001ex99-2_enlivex.htm EX-99.2 19253
12 INVESTOR PRESENTATION ea026687001ex99-3_enlivex.htm EX-99.3 36023
13 GRAPHIC ex5-1_001.jpg GRAPHIC 19192
14 GRAPHIC ex99-2_001.jpg GRAPHIC 2375
15 GRAPHIC ex99-3_001.jpg GRAPHIC 195530
16 GRAPHIC ex99-3_002.jpg GRAPHIC 812493
17 GRAPHIC ex99-3_003.jpg GRAPHIC 348653
18 GRAPHIC ex99-3_004.jpg GRAPHIC 312029
19 GRAPHIC ex99-3_005.jpg GRAPHIC 375806
20 GRAPHIC ex99-3_006.jpg GRAPHIC 378339
21 GRAPHIC ex99-3_007.jpg GRAPHIC 532689
22 GRAPHIC ex99-3_008.jpg GRAPHIC 268134
23 GRAPHIC ex99-3_009.jpg GRAPHIC 316907
24 GRAPHIC ex99-3_010.jpg GRAPHIC 290294
25 GRAPHIC ex99-3_011.jpg GRAPHIC 322469
26 GRAPHIC ex99-3_012.jpg GRAPHIC 433512
27 GRAPHIC ex99-3_013.jpg GRAPHIC 319662
28 GRAPHIC ex99-3_014.jpg GRAPHIC 314728
29 GRAPHIC ex99-3_015.jpg GRAPHIC 252906
30 GRAPHIC ex99-3_016.jpg GRAPHIC 344193
31 GRAPHIC ex99-3_017.jpg GRAPHIC 278782
32 GRAPHIC ex99-3_018.jpg GRAPHIC 337979
33 GRAPHIC ex99-3_019.jpg GRAPHIC 358457
34 GRAPHIC ex99-3_020.jpg GRAPHIC 300891
35 GRAPHIC ex99-3_021.jpg GRAPHIC 175144
36 GRAPHIC ex99-3_022.jpg GRAPHIC 366619
37 GRAPHIC ex99-3_023.jpg GRAPHIC 295241
38 GRAPHIC ex99-3_024.jpg GRAPHIC 456004
39 GRAPHIC ex99-3_025.jpg GRAPHIC 325824
40 GRAPHIC ex99-3_026.jpg GRAPHIC 332180
  Complete submission text file 0001213900-25-113881.txt   13840113
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV Israel 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36578 | Film No.: 251509772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)